PACS today
$48.32+$0.32 (+0.67%)close Nov 13, 2026Trend
DailyUptrend (confirmed)
4 hourBearish
1 hourStrong Bearish
15 minStrong Bearish
5 minSymmetric Triangle
Daily trend turns down below $45.39
Key levels
Resistance$51.68
Resistance$49.49
Support$46.25
Support$43.52
Latest news & SEC filings
SEC FilingPACS Group, Inc. filed an insider trading report (Form 4)
AnalystUBS keeps Buy rating on PACS Group, lifts target to $67
All PACS news →About PACS Group
PACS Group runs skilled nursing homes and other residential care settings for older adults in the United States. It buys struggling long-term care properties and turns them into centers focused on short-term recovery and rehabilitation. Patients are mostly people leaving hospitals who still need round-the-clock care, and the company gets paid mainly by government health programs. Its facilities are spread across many states.
Based on the company's 10-K filed Feb 27, 2026.
NYSE · Healthcare
PACS Group, Inc. (PACS)
What Is the Price Target for PACS?
SEPT Low Target
$57.00
SEPT Mid Target
$58.00
SEPT High Target
$62.00
Analyst Consensus
$58.00
Is PACS a Buy or Sell Right Now?
Thesis
- •Revenue growing 29.3% YoY with STRONG trend — consistent growth.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for PACS.
Start Free Trial →Is PACS Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/E Forward, P/B, PEG, Analyst Consensus
Fair Value
$60.48
36
Moat Score
NONE
7/9
Piotroski Score
2.2
Altman Z-Score
What Is Smart Money Doing with PACS?
Insider Signal
SELLING
0 buys / 20 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Jergensen Joshua | officer | Sale | 7,283 | $357K | Nov 11, 2026 |
| Jergensen Joshua | officer | Sale | 30,577 | $1.5M | Nov 11, 2026 |
| Jergensen Joshua | officer | Sale | 2,140 | $109K | Nov 11, 2026 |
| Murray Jason Hulse | director officer 10% owner | Sale | 4,000 | $190K | Nov 4, 2026 |
| Murray Jason Hulse | director officer 10% owner | Sale | 6,197 | $301K | Nov 4, 2026 |
| Murray Jason Hulse | director officer 10% owner | Sale | 12,333 | $612K | Nov 4, 2026 |
| Murray Jason Hulse | director officer 10% owner | Sale | 133,314 | $6.7M | Nov 4, 2026 |
| Murray Jason Hulse | director officer 10% owner | Sale | 11,590 | $595K | Nov 4, 2026 |
| Hancock Mark | director 10% owner | Sale | 174,937 | $8.8M | Nov 4, 2026 |
| Hancock Mark | director 10% owner | Sale | 11,759 | $605K | Nov 4, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →PACS Growth Story
Revenue YoY
29.3%
3yr Revenue CAGR
29.7%
EPS Growth YoY
221.05%
FCF Growth YoY
N/A%
Revenue Trend
STRONG
Dark Pool Trades for PACS
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for PACS, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 17:52:06 | $47.80 | 2,000 | $$96K | SELL |
| 17:50:12 | $47.90 | 4,920 | $$236K | BUY |
| 17:14:56 | $47.67 | 1,000 | $$48K | SELL |
| 16:45:40 | $47.69 | 4,931 | $$235K | BUY |
| 16:15:47 | $47.41 | 1,784 | $$85K | MIDPOINT |
5 dark pool trades shown · $$699K preview volume
Real-time institutional flow, block trades, and net positioning
Options Flow for PACS
PREVIEWSEPT Investing provides real-time options flow tracking for PACS, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| CALL | $50 | Jan 15 | 63 | $$75.0K | 250 | BLOCK |
1 options trades shown · 100% calls
Unusual activity, GEX levels, max pain, and dealer positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for PACS Group, Inc. (PACS) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (3 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →PACS — frequently asked questions
What is PACS stock price today?
PACS Group, Inc. (PACS) is at $48.32, up 0.67% (+$0.32) at the Nov 13, 2026 close.
Why is PACS stock moving today?
Latest PACS news — Nov 12, 2026: PACS Group, Inc. filed an insider trading report (Form 4) · Nov 5, 2026: UBS keeps Buy rating on PACS Group, lifts target to $67
What is the PACS price target?
The average analyst price target for PACS is $58.00, ranging from $57 to $62, based on 5 analysts. Latest: JP Morgan maintains on Sep 4, 2026.
What do analysts rate PACS?
Analyst ratings for PACS: 0 Buy, 8 Hold, 0 Sell — consensus Hold.
Did PACS beat earnings?
PACS last reported on Aug 4, 2026: EPS $0.63 vs $0.54 expected — a beat of 17.3%.
What is PACS's P/E ratio?
PACS trades at a P/E of 27.2 vs a Healthcare average of 17.8.
Does PACS pay a dividend?
PACS does not currently pay a dividend.
What are PACS support and resistance levels?
Support: $46.25, $43.52, $40.55. Resistance: $49.49, $51.68.
What are insiders doing with PACS?
Insider activity: SELLING, 0 buys and 20 sells in the last 90 days.
What is the latest news on PACS?
Nov 12, 2026: PACS Group, Inc. filed an insider trading report (Form 4) · Nov 5, 2026: UBS keeps Buy rating on PACS Group, lifts target to $67